60 results
8-K
NUWE
Nuwellis Inc
26 Mar 24
Other Events
5:00pm
) in an acute care environment during the COVID-19 pandemic. Additionally, Medtronic and DaVita have recently formed a joint venture, called Mozarc Medical
8-K
EX-99.1
NUWE
Nuwellis Inc
8 Jan 24
Regulation FD Disclosure
9:24am
to liver, LVAD, and oncology $14.1M $10.5M $15.4M $17.3M $72.8M $33.6M $$ ACT II 2020‐2021 Persevered through the Pandemic and more Weathered … the pandemic storm and grew the business Launched REVERSE‐HF trial in 20 target sites centers Initiated Vivian product development with $1.7 million NIH grant
8-K
EX-99.1
dyt9gddq
10 Oct 23
Other Events
8:30am
8-K
EX-99.1
nx2arxx
20 Jun 23
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select Markets
6:55pm
8-K
EX-99.1
btqno nwi
9 May 23
Nuwellis, Inc. Announces First Quarter 2023 Financial Results
8:15am
8-K
EX-99.1
1ohwv1h
29 Dec 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-99.1
h53rcrjmh
27 Dec 22
Nuwellis, Inc. Announces Compliance With Nasdaq Listing Requirements
5:28pm
8-K
EX-99.1
sbij0j63i
30 Nov 22
Nuwellis, Inc. Receives 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement
9:10am
8-K
EX-99.1
om8wmbca
8 Nov 22
Nuwellis, Inc. Reports Third Quarter 2022 Financial Results
6:01am
8-K
EX-99.1
4fgfju9 5q
18 Oct 22
Nuwellis Announces Pricing of $9.6 Million Upsized Underwritten Public Offering
4:26pm
8-K
EX-99.2
8bsgnd20960
18 Oct 22
Nuwellis Announces Pricing of $9.6 Million Upsized Underwritten Public Offering
4:26pm
8-K
EX-99.1
rtt9nofj ka
3 Oct 22
Other Events
8:47am
8-K
EX-99.1
vm4za7
27 Sep 22
Nuwellis Announces the Activation of New Sites for Its Pivotal Reverse-hf Trial
8:59am